Number of the records: 1  

Prolongation of pentoxifylline aliphatic side chain positively affects the reversal of p-glycoprotein-mediated multidrug resistance in L1210/VCR line cells

  1. TitleProlongation of pentoxifylline aliphatic side chain positively affects the reversal of p-glycoprotein-mediated multidrug resistance in L1210/VCR line cells
    Author Dočolomanský Peter SAVMOFYZ - Ústav molekulárnej fyziológie a genetiky SAV
    Co-authors Fialová Ivana SAVMOFYZ - Ústav molekulárnej fyziológie a genetiky SAV

    Barančík Miroslav 1962- SAVSRDCE - Ústav pre výskum srdca SAV    SCOPUS

    Rybar Alfonz SAVCHEM - Chemický ústav SAV

    Breier Albert 1957- SAVMOFYZ - Ústav molekulárnej fyziológie a genetiky SAV    SCOPUS    RID    ORCID

    Source document General physiology and biophysics. Vol. 24, Issue 4 (2005), p. 461-466
    Languageeng - English
    CountrySK - Slovak Republic
    Document kindrozpis článkov z periodík (rbx)
    CitationsPATANE, Salvatore. Cancer multidrug resistance-targeted therapy in both cancer and cardiovascular system with cardiovascular drugs. In INTERNATIONAL JOURNAL OF CARDIOLOGY. ISSN 0167-5273, 2014, vol. 176, no. 3, pp. 1306.
    WANG, Ying - ZHAO, Yating - CUI, Yu - ZHAO, Qinfu - ZHANG, Qiang - MUSETTI, Sara - KINGHORN, Karina A. - WANG, Siling. Overcoming multiple gastrointestinal barriers by bilayer modified hollow mesoporous silica nanocarriers. In ACTA BIOMATERIALIA. ISSN 1742-7061, 2018, vol. 65, no., pp. 405-416.
    CategoryADDA - Scientific papers in domestic journals registered in Current Contents Connect with IF (impacted)
    Category of document (from 2022)V3 - Vedecký výstup publikačnej činnosti z časopisu
    Type of documentčlánok
    Year2005
    Registered inWOS
    Registered inSCOPUS
    Registered inCCC
    article

    article

    rokCCIFIF Q (best)JCR Av Jour IF PercSJRSJR Q (best)CiteScore
    A
    rok vydaniarok metrikyIFIF Q (best)SJRSJR Q (best)
    200520040.694
Number of the records: 1  

  This site uses cookies to make them easier to browse. Learn more about how we use cookies.